钼靶摄片与核磁共振在乳腺癌诊断中的比较  

Comparison of Molybdenum Target and Nuclear Magnetic Resonance in Diagnosis of Breast Cancer

作　　者：陈垦 杨世平 朱兰 王聪 凌洪 余涛 Chen Ken;Yang Shiping;Zhu Lan;Wang Cong;Ling Hong;Yu Tao(Department of Radiology,Sichuan Baoshihua Hospital (610213))

机构地区：[1]四川宝石花医院放射科

出　　处：《现代医用影像学》2019年第7期1541-1542,1545,共3页Modern Medical Imageology

摘　　要：目的:比较钼靶摄片与核磁共振诊断乳腺癌的诊断效果。方法:采用医学研究对比法,选定我院收治的80例乳腺癌患者,依照诊断方式不同,等分为对照组和观察组,分别应用核磁共振和钼靶摄片诊断,临床比对和观察两组诊断效果。结果:观察组诊断效果97.50%(39/40)显著高于对照组80.00%(32/40),有统计学意义(P<0.05)。结论:核磁共振诊断对乳腺癌患者效果确切,比之钼靶摄片诊断具有较高的诊断正确率,值得临床大力推广。Objective:To compare the diagnostic effects of mammography and nuclear magnetic resonance imaging in the diagnosis of breast cancer.Methods:80 cases of breast cancer patients admitted to our hospital were selected according to the medical research comparison method. According to the different diagnostic methods, they were divided into the control group and the observation group. The diagnosis of NMR and molybdenum target was used respectively. Clinical comparison and observation The two groups have diagnostic effects.Results:The diagnostic effect of the observation group was 97.50%(39/40), which was significantly higher than that of the control group(80.00%, 32/40), which was statistically significant(P<0.05).Conclusion:The diagnosis of breast cancer is effective in the diagnosis of breast cancer patients. It has a higher diagnostic accuracy than the diagnosis of molybdenum target tablets, which is worthy of clinical promotion.

关 键 词：钼靶摄片 核磁共振 乳腺癌 诊断 

分 类 号：R737.9[医药卫生—肿瘤] R445.2[医药卫生—临床医学]